Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritis

Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritis

Abstract Background Aiming at rapid decrease of disease activity, there has been a trend to start with higher doses of methotrexate (MTX) in patients newly diagnosed with rheumatoid arthritis (RA), both as monotherapy and in combination with other antirheumatic drugs. We aimed to study the relations...

Full description

Bibliographic Details
Main Authors: Sytske Anne Bergstra, Cornelia F. Allaart, Rosaline van den Berg, Arvind Chopra, Nimmisha Govind, Tom W. J. Huizinga, Robert B. M. Landewe
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Arthritis Research & Therapy
Subjects:
Rheumatoid arthritis
Methotrexate
Dose
Outcome measures
Combination therapy
Online Access:http://link.springer.com/article/10.1186/s13075-017-1468-9

Internet

http://link.springer.com/article/10.1186/s13075-017-1468-9

Similar Items